Parameter
| Biomarker | SOD1 | Full name | Superoxide Dismutase 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis, risk stratification | ||
| Disease | Acute Myeloid Leukemia (AML) | Disease Subtypes | / | ||
| Organ | Blood, bone marrow | Test Sample / Technology Platform | Bone marrow (RNA sequencing, siRNA validation) | ||
| Pathobiological Mechanisms | High expression is involved in the proliferation regulation of AML cells and associated with disease progression. | ||||
| Clinical Availability Status | Research validation: Enhanced risk stratification accuracy when combined with the other three factors. | ||||
| Notes and Dynamics | Targeted inhibition can serve as one of the combination therapy strategies. | ||||